[Use of rituximab in maintenance treatment of pemphigus: A retrospective series].

[1]  M. Saleh.  A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab , 2018, Journal of the American Academy of Dermatology.

[2]  K. Kridin.  Emerging treatment options for the management of pemphigus vulgaris , 2018, Therapeutics and clinical risk management.

[3]  F. Antonicelli,et al.  Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus , 2018, JAMA dermatology.

[4]  L. Sailler,et al.  Pneumocystis jirovecii pneumonia in patients treated with rituximab for systemic diseases: Report of 11 cases and review of the literature. , 2017, European journal of internal medicine.

[5]  L. Naldi,et al.  Rituximab as first‐line adjuvant therapy for pemphigus: Retrospective analysis of long‐term outcomes at a single center , 2017, Journal of the American Academy of Dermatology.

[6]  O. Dereure,et al.  First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial , 2017, The Lancet.

[7]  J. Lacour,et al.  Incidence et mortalité du pemphigus en France , 2016 .

[8]  K. Amber,et al.  An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  D. Murrell,et al.  Pemphigus Vulgaris: An Evidence-Based Treatment Update , 2015, Drugs.

[10]  N. Soter,et al.  Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients , 2013, The British journal of dermatology.

[11]  E. Hodak,et al.  Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients. , 2013, Journal of the American Academy of Dermatology.

[12]  A. Ahmed,et al.  Rituximab in the Treatment of Pemphigus Vulgaris , 2012, Dermatology and Therapy.

[13]  R. Corona,et al.  Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up. , 2012, Journal of the American Academy of Dermatology.

[14]  K. Propert,et al.  Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients. , 2012, Archives of dermatology.

[15]  R. Letestu,et al.  Rituximab for patients with refractory mucous membrane pemphigoid. , 2011, Archives of dermatology.

[16]  J. Roujeau,et al.  B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses. , 2008, The Journal of investigative dermatology.

[17]  J. Roujeau,et al.  A single cycle of rituximab for the treatment of severe pemphigus. , 2007, The New England journal of medicine.

[18]  C. Sitaru,et al.  Immunopathology and molecular diagnosis of autoimmune bullous diseases , 2007, Journal of cellular and molecular medicine.

[19]  Yu-Chen Huang,et al.  Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens. , 2015, Acta dermato-venereologica.

[20]  D. Murrell,et al.  The Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus , 2015 .